NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Histologically confirmed locally advanced or metastatic solid tumor
(Strata A, B, D):
Specification for Stratum C: Only patients with NSCLC adenocarcinomas,
(squamous or adenosquamous not permitted) who are scheduled to
receive platin + pembrolizumab + pemetrexed standard treatment (only
for Stratum C)
Specification for Stratum E: Including only metastatic or irresectable
locally advanced urothelial carcinomas (only for Stratum E)
1 total trials
Filter these 1 trials by phase, country, sponsor and more.